Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 2, Pages 144
Publisher
MDPI AG
Online
2019-01-29
DOI
10.3390/cancers11020144
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overview upon miR-21 in lung cancer: focus on NSCLC
- (2018) Cecilia Bica-Pop et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The prognostic value of microRNA-183 in human cancers
- (2018) Xiao-long Zhang et al. MEDICINE
- Pharmacoepigenetics in childhood acute lymphoblastic leukemia: involvement of miRNA polymorphisms in hepatotoxicity
- (2018) Angela Gutierrez-Camino et al. Epigenomics
- Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
- (2018) Maria Lopez-Santillan et al. Oncotarget
- Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer
- (2018) Lorenzo Stramucci et al. Cancers
- Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
- (2018) Jens C. Hahne et al. Frontiers in Oncology
- HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma
- (2017) Y J Jia et al. LEUKEMIA
- Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma
- (2017) Jia Song et al. MEDICINE
- MicroRNA‑21 regulates the viability and apoptosis of diffuse large B‑cell lymphoma cells by upregulating B cell lymphoma‑2
- (2017) Ke Liu et al. Experimental and Therapeutic Medicine
- The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
- (2017) Qiliang Peng et al. Oncotarget
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma
- (2016) Sara Correia Marques et al. EXPERIMENTAL HEMATOLOGY
- MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma
- (2016) Fu-qiang Zhu et al. ONCOLOGY RESEARCH
- miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma
- (2016) Qian Fan et al. Protein & Cell
- Low expression of miRNA-224 predicts poor clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP
- (2015) Huiyun Ni et al. BIOMARKERS
- Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas
- (2015) Hana Huskova et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients
- (2015) Katharina Troppan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma
- (2015) Daniel Shepshelovich et al. LEUKEMIA RESEARCH
- miRWalk2.0: a comprehensive atlas of microRNA-target interactions
- (2015) Harsh Dweep et al. NATURE METHODS
- KEGG as a reference resource for gene and protein annotation
- (2015) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- The Reactome pathway Knowledgebase
- (2015) Antonio Fabregat et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma
- (2015) Heounjeong Go et al. Oncotarget
- Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients
- (2015) Emilia L Lim et al. GENOME BIOLOGY
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
- (2014) J. Iqbal et al. BLOOD
- Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone
- (2014) Peng Yan Wu et al. HUMAN PATHOLOGY
- MicroRNAs in B-cell lymphomas: how a complex biology gets more complex
- (2014) K Musilova et al. LEUKEMIA
- Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphoma
- (2014) Penny Anders et al. LEUKEMIA & LYMPHOMA
- MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma
- (2014) Wan-ling Wang et al. MEDICAL ONCOLOGY
- miRBase: annotating high confidence microRNAs using deep sequencing data
- (2013) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Genetic heterogeneity of diffuse large B-cell lymphoma
- (2013) Jenny Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma
- (2013) S Caramuta et al. Blood Cancer Journal
- Quantitative Proteomics Reveals that miR-155 Regulates the PI3K-AKT Pathway in Diffuse Large B-Cell Lymphoma
- (2012) Xin Huang et al. AMERICAN JOURNAL OF PATHOLOGY
- The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies
- (2012) Ambrogio Fassina et al. LABORATORY INVESTIGATION
- The ConsensusPathDB interaction database: 2013 update
- (2012) Atanas Kamburov et al. NUCLEIC ACIDS RESEARCH
- High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma
- (2012) MATTIAS BERGLUND et al. ONCOLOGY REPORTS
- MicroRNAs miR-125a and miR-125b constitutively activate the NF- B pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)
- (2012) S.-W. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma
- (2012) HUA ZHONG et al. Experimental and Therapeutic Medicine
- miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
- (2011) S. Montes-Moreno et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
- (2011) A. J. Alencar et al. CLINICAL CANCER RESEARCH
- FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells
- (2011) N McInnes et al. ONCOGENE
- Epigenetic Down-Regulation of the Tumor Suppressor Gene PRDM1/Blimp-1 in Diffuse Large B Cell Lymphomas
- (2010) Kui Nie et al. AMERICAN JOURNAL OF PATHOLOGY
- Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
- (2010) B. Coiffier et al. BLOOD
- Patterns of microRNA expression characterize stages of human B-cell differentiation
- (2009) Jenny Zhang et al. BLOOD
- Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas
- (2009) Irene M. Pedersen et al. EMBO Molecular Medicine
- Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas
- (2008) R. Malumbres et al. BLOOD
- MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas
- (2008) Anja Roehle et al. BRITISH JOURNAL OF HAEMATOLOGY
- Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma
- (2008) Charles H. Lawrie et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started